USANA Health Sciences Files Q3 2024 10-Q
Ticker: USNA · Form: 10-Q · Filed: 2024-11-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
USANA Health Sciences filed its Q3 2024 10-Q, detailing financial performance for the period ending Sept 28.
AI Summary
USANA Health Sciences Inc. reported its third-quarter results for the period ending September 28, 2024. The company's filing indicates financial data and operational details for this period. Specific financial figures and performance metrics are detailed within the report.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for USANA Health Sciences, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and market conditions can introduce medium-level risk.
Key Numbers
- 20240928 — Period End Date (The end of the reporting quarter for which financial data is provided.)
- 20241105 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Filer
- SALT LAKE CITY (location) — Business Address City
- UT (location) — Business Address State
- 20240928 (date) — Period of Report
- 20241105 (date) — Filed as of Date
FAQ
What is the fiscal year end for USANA Health Sciences Inc.?
The fiscal year end for USANA Health Sciences Inc. is December 28.
What is the Standard Industrial Classification code for USANA Health Sciences Inc.?
The Standard Industrial Classification code for USANA Health Sciences Inc. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
In which state was USANA Health Sciences Inc. incorporated?
USANA Health Sciences Inc. was incorporated in Utah (UT).
What is the SEC file number for USANA Health Sciences Inc.?
The SEC file number for USANA Health Sciences Inc. is 001-35024.
What is the business phone number listed for USANA Health Sciences Inc.?
The business phone number listed for USANA Health Sciences Inc. is 8019547100.
From the Filing
0000896264-24-000222.txt : 20241105 0000896264-24-000222.hdr.sgml : 20241105 20241105125604 ACCESSION NUMBER: 0000896264-24-000222 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20240928 FILED AS OF DATE: 20241105 DATE AS OF CHANGE: 20241105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 241426608 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 10-Q 1 usna-20240928.htm 10-Q usna-20240928 0000896264 12/28 2024 Q3 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares usna:region xbrli:pure usna:segment 0000896264 2023-12-31 2024-09-28 0000896264 2024-11-01 0000896264 2024-09-28 0000896264 2023-12-30 0000896264 2024-06-30 2024-09-28 0000896264 2023-07-02 2023-09-30 0000896264 2023-01-01 2023-09-30 0000896264 us-gaap:CommonStockMember 2022-12-31 0000896264 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2022-12-31 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000896264 2022-12-31 0000896264 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000896264 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000896264 us-gaap:CommonStockMember 2023-09-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000896264 us-gaap:RetainedEarningsMember 2023-09-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000896264 2023-09-30 0000896264 us-gaap:CommonStockMember 2023-12-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000896264 us-gaap:RetainedEarningsMember 2023-12-31 2024-09-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 2024-09-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 2024-09-28 0000896264 us-gaap:CommonStockMember 2023-12-31 2024-09-28 0000896264 us-gaap:CommonStockMember 2024-09-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-09-28 0000896264 us-gaap:RetainedEarningsMember 2024-09-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-28 0000896264 us-gaap:CommonStockMember 2023-07-01 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 0000896264 us-gaap:RetainedEarningsMember 2023-07-01 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 0000896264 2023-07-01 0000896264 us-gaap:RetainedEarningsMember 2023-07-02 2023-09-30 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 2023-09-30 0000896264 us-gaap:AdditionalPaidInCapitalMember 2023-07-02 2023-09-30 0000896264 us-gaap:CommonStockMember 2023-07-02 2023-09-30 0000896264 us-gaap:CommonStockMember 2024-06-29 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-06-29 0000896264 us-gaap:RetainedEarningsMember 2024-06-29 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-29 0000896264 2024-06-29 0000896264 us-gaap:RetainedEarningsMember 2024-06-30 2024-09-28 0000896264 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 2024-09-28 0000896264 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 2024-09-28 0000896264 us-gaap:CommonStockMember 2024-06-30 2024-09-28 0000896264 us-gaap:MoneyMarketFundsMember